Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lothar Heilmann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 13, 2010
CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatmentLothar Heilmann, Martin Schorsch, Thomas Hahn
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 20, 2007
Hemostatic abnormalities in patients with severe preeclampsiaLothar Heilmann, Werner Rath, Kunhard Pollow
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2003
ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndromeLothar Heilmann, Georg-Friedrich von Tempelhoff, Kuhnhart Pollow
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 19, 2003
Antiphospholipid syndrome in obstetricsLothar Heilmann, Georg-Friedrich von Tempelhoff, Kunhard Pollow
Breast Cancer Research and Treatment|August 6, 2002
Thrombosis--a clue of poor prognosis in primary non-metastatic breast cancer?Georg-Friedrich von Tempelhoff, Nicole Schönmann, Lothar Heilmann
Seminars in Thrombosis and Hemostasis|March 4, 2011
Antiphospholipid syndrome and pre-eclampsiaLothar Heilmann, Martin Schorsch, Thomas Hahn, et al.
Seminars in Thrombosis and Hemostasis|November 25, 2003
Impact of rheological variables in cancerGeorg-Friedrich von Tempelhoff, Lothar Heilmann, Gerhard Hommel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2004
Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancerGeorg-Friedrich von Tempelhoff, Lothar Heilmann, Kunhard Pollow, et al.
Clinical Hemorheology and Microcirculation|March 21, 2002
Prognostic role of plasmaviscosity in breast cancerGeorg-Friedrich von Tempelhoff, Nicole Schönmann, Lothar Heilmann, et al.
Thrombosis Research|April 5, 2003
A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitroBernd Klein, Andreé Faridi, G F von Tempelhoff, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 13, 2010
CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatmentLothar Heilmann, Martin Schorsch, Thomas Hahn
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 20, 2007
Hemostatic abnormalities in patients with severe preeclampsiaLothar Heilmann, Werner Rath, Kunhard Pollow
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2003
ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndromeLothar Heilmann, Georg-Friedrich von Tempelhoff, Kuhnhart Pollow
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 19, 2003
Antiphospholipid syndrome in obstetricsLothar Heilmann, Georg-Friedrich von Tempelhoff, Kunhard Pollow
Breast Cancer Research and Treatment|August 6, 2002
Thrombosis--a clue of poor prognosis in primary non-metastatic breast cancer?Georg-Friedrich von Tempelhoff, Nicole Schönmann, Lothar Heilmann
Seminars in Thrombosis and Hemostasis|March 4, 2011
Antiphospholipid syndrome and pre-eclampsiaLothar Heilmann, Martin Schorsch, Thomas Hahn, et al.
Seminars in Thrombosis and Hemostasis|November 25, 2003
Impact of rheological variables in cancerGeorg-Friedrich von Tempelhoff, Lothar Heilmann, Gerhard Hommel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2004
Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancerGeorg-Friedrich von Tempelhoff, Lothar Heilmann, Kunhard Pollow, et al.
Clinical Hemorheology and Microcirculation|March 21, 2002
Prognostic role of plasmaviscosity in breast cancerGeorg-Friedrich von Tempelhoff, Nicole Schönmann, Lothar Heilmann, et al.
Thrombosis Research|April 5, 2003
A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitroBernd Klein, Andreé Faridi, G F von Tempelhoff, et al.
Pageof 2